Beijing Beilu Pharmaceutical Co., Ltd
About Beijing Beilu Pharmaceutical Co., Ltd
Categories

-
CN
-
2018On CPHI since
-
1000 - 4999Employees
Company types
Meet us at
CPHI Frankfurt 2025
Messe Frankfurt
28 Oct 2025 - 30 Oct 2025
Products from Beijing Beilu Pharmaceutical Co., Ltd (5)
-
Product gadobutrol
In 2020, Beilu launched its macrocyclic Contrast Media- Gadobutrol Injection, it is gadolinium-based non-ionic Contrast Media, a paramagnetic Contrast Media used in various parts of the body lesion (including the brain and spinal cord) MRI imaging and angiography examination. Its macrocyclic nature ensures... -
Product gadopentetate Dimeglumine
Since Gadopentetate Dimeglumine Injection was launched in 1992 by Beilu Pharma in China, it was highly recommended and accepted by the radiologist, and quickly occupied the market with its excellent quality and reasonable price. Up to now, linear gadolinium has been safely used for nearly 30 years, with ex... -
Product iodixanol
Iodixanol Injection is a CT/X-ray Contrast Media that is isotonic with plasma. It has excellent cardiac safety and renal safety, which is most comfortable to use, especially suitable for high risk patients. Gadopentetate Dimeglumine Injection is also available here. Product name: Iodixanol Injection Ge... -
Product iohexol
Iohexol Injection is one of the different types of contrast media. Compared with a traditional ionic Contrast Media, Iohexol Injection has an excellent molecular structure and it can greatly improve user safety and significantly reduce adverse reactions. The iodinated contrast agent has excellent clinical... -
Product Iopamidol
Iopamidol Injection is the second-generation non-ionic iodinated Contrast Media launched in the global market. In 2015, Beilu firstly launched and listed Iopamidol Injection, one of the most widely used types of contrast medium in the Chinese market. Product name: Iopamidol Injectionnon Generic name: ...